Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?

References

• Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728–745.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Pfaar O, Togias A, et al. ARIA care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087–2102.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63(Suppl 86):8–160.
   PubMed Web of Science ®Google Scholar
• Roche N, Anzueto A, Bosnic Anticevich S, et al. The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization. Eur Respir J. 2019;54(3):1901511.
   Google Scholar
• Devillier P, Wahn U, Zielen S, et al. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis. Expert Rev Clin Immunol. 2017;13(12):1199–1206.
   PubMed Web of Science ®Google Scholar
• Murphy K, Gawchik S, Bernstein D, et al. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma. J Negat Results Biomed. 2013;12:10.
   PubMedGoogle Scholar
• Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6(1):11–23.
   PubMed Web of Science ®Google Scholar
• Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy. 2004;59(5):498–504.
   PubMed Web of Science ®Google Scholar
• Röder E, Berger MY, Hop WC, et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol. 2007;119(4):892–898.
   PubMed Web of Science ®Google Scholar
• Cziraky M, Pollock M. Applied clinical trials. Real-world evidence studies 2015 [March 2019]. Available from: https://www.appliedclinicaltrialsonline.com/real-world-evidence-studies
   Google Scholar
• Herland K, Akselsen JP, Skjonsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med. 2005;99(1):11–19.
   PubMed Web of Science ®Google Scholar
• Costa DJ, Amouyal M, Lambert P, et al. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol. 2011;127(4):920–926e1.
   PubMed Web of Science ®Google Scholar
• Price D, Brusselle G, Roche N, et al. Real-world research and its importance in respiratory medicine. Breathe (Sheff). 2015;11(1):26–38.
   PubMedGoogle Scholar
• Blonde L, Khunti K, Harris SB, et al. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763–1774.
   PubMed Web of Science ®Google Scholar
• Devillier P, Molimard M, Ansolabehere X, et al. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France. Allergy. 2019;74(7):1317–1326.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Schwarz K, Stadler E, et al. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study. J Allergy Clin Immunol. 2015;136(6):1511–1516.
   PubMed Web of Science ®Google Scholar
• Wahn U, Bachert C, Heinrich J, et al. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019;74(3):594–604.
   PubMed Web of Science ®Google Scholar
• Zielen S, Devillier P, Heinrich J, et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis. Allergy. 2018;73(1):165–177.
   PubMed Web of Science ®Google Scholar
• Didier A, Wahn U, Horak F, et al. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience. Expert Rev Clin Immunol. 2014;10(10):1309–1324.
   PubMed Web of Science ®Google Scholar
• Voltolini S, Modena P, Minale P, et al. Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Madr). 2001;29(4):103–110.
   PubMedGoogle Scholar
• Worm M, Rak S, de Blay F, et al. Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study. Clin Transl Allergy. 2014;4(1):7.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy rganization position paper 2013 update. World Allergy Organ J. 2014;7(1):6.
   PubMedGoogle Scholar
• Casale TB, Canonica GW, Bousquet J, et al. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol. 2009;124(4):665–670.
   PubMed Web of Science ®Google Scholar
• Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI position paper. Allergy. 2017;72(8):1156–1173.
   PubMed Web of Science ®Google Scholar
• Calderón MA, Frankland AW, Demoly P. Allergen immunotherapy and allergic rhinitis: false beliefs. BMC Med. 2013;11:255.
   PubMed Web of Science ®Google Scholar
• Calderón MA, Cox L, Casale TB, et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol. 2012;129(4):929–934.
   PubMed Web of Science ®Google Scholar
• Demoly P, Okamoto Y, Yang WH, et al. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis. Expert Rev Clin Immunol. 2016;12(11):1141–1151.
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–568.
   PubMed Web of Science ®Google Scholar
• Saturni S, Bellini F, Braido F, et al. Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view. Pulm Pharmacol Ther. 2014;27(2):129–138.
   PubMed Web of Science ®Google Scholar
• Howarth P, Malling HJ, Molimard M, et al. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients. Allergy. 2012;67(3):321–327.
   PubMed Web of Science ®Google Scholar
• Sade K, Berkun Y, Dolev Z, et al. Knowledge and expectations of patients receiving aeroallergen immunotherapy. Ann Allergy Asthma Immunol. 2003;91(5):444–448.
   PubMed Web of Science ®Google Scholar
• Allam JP, Andreasen JN, Mette J, et al. Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany. J Allergy Clin Immunol. 2018;141(5):1898–901 e5.
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Mauro M, Leo G, et al. Adherence to sublingual immunotherapy. Curr Allergy Asthma Rep. 2016;16(2):12.
   PubMed Web of Science ®Google Scholar
• Lemberg ML, Berk T, Shah-Hosseini K, et al. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence. 2017;11:63–70.
   PubMed Web of Science ®Google Scholar
• Senna G, Caminati M, Canonica GW. Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol. 2013;13(6):656–662.
   PubMed Web of Science ®Google Scholar
• Bachert C, Larche M, Bonini S, et al. Allergen immunotherapy on the way to product-based evaluation – a WAO statement. World Allergy Organ J. 2015;8(1):29.
   PubMed Web of Science ®Google Scholar
• Pfaar O, Lou H, Zhang Y, et al. Recent developments and highlights in allergen immunotherapy. Allergy. 2018;73(12):2274–2289.
   PubMed Web of Science ®Google Scholar
• Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135–43 e6.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018;73(9):1763–1774.
   PubMed Web of Science ®Google Scholar
• Bousquet JJ, Schunemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44.
   PubMed Web of Science ®Google Scholar